Ylva Karlsson
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Whole-Body MRI Surveillance-Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53).
Journal: Cancers
Published: December 08, 2021
A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients.
Journal: Scientific reports
Published: April 18, 2021
A retrospective two centre study of Birt-Hogg-Dubé syndrome reveals a pathogenic founder mutation in FLCN in the Swedish population.
Journal: PloS one
Published: January 22, 2021
Novel variants in Nordic patients referred for genetic testing of telomere-related disorders.
Journal: European journal of human genetics : EJHG
Published: July 13, 2017
The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium.
Journal: Journal of medical genetics
Published: January 24, 2017
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.
Journal: Nature genetics
Published: May 30, 2016
Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
Journal: PloS one
Published: March 12, 2016
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
Journal: Breast cancer research : BCR
Published: December 23, 2015
Telomerase antagonist imetelstat inhibits esophageal cancer cell growth and increases radiation-induced DNA breaks.
Journal: Biochimica et biophysica acta
Published: December 24, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026